Chinese officials have detained 22 GlaxoSmithKline (GSK) employees and an unknown number of doctors in the last month, accusing them of misdeeds and bribery. The company is one of about 60 biopharmas currently under investigation by Beijing for pricing policies. (Learn more here.) Do you expect this scandal will have a lasting effect on China’s biopharma industry?

Poll Question:
What long-term effect will the GSK scandal have on the biopharma industry in China?

No effect

Little effect

A big effect

Get out now, while you have the chance!

Previous articleAstraZeneca to Co-Develop FibroGen Anemia Compound in Up to $815M Deal
Next articleNIH Awards SAGE Up to $10M for Fragile X Syndrome Treatment